Francesca Lo Bianco

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 06, 2026

Temporal patterns and factors associated with early termination in phase 1 clinical trials for solid tumors.

Temporal patterns and factors associated with early termination in phase 1 clinical trials for solid tumors.

Journal: Journal of the National Cancer Institute

Published: December 22, 2025

Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression.

Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression.

Journal: ESMO open

Published: November 14, 2025

Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data.

Efficacy of Adding Immune Checkpoint Inhibition to Chemotherapy, With or Without VEGF Inhibition, in Patients With Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data.

Journal: JTO clinical and research reports

Published: November 13, 2025

Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals.

Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals.

Journal: Frontiers in oncology

Published: October 01, 2025

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.

Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.

Journal: The Lancet. Oncology

Published: February 03, 2025

Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report.

Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 11, 2024

Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature.

Multidisciplinary approach, continuous care and opioid management in cancer pain: case series and review of the literature.

Journal: Drugs in context

Published: November 21, 2022

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 11, 2022

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer.

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer.

Journal: Cancers

Published: June 25, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026